PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations: Molecular Therapy

JCM, Free Full-Text

The Role of Coenzyme Q10 in Statin-Associated Myopathy: A Systematic Review

Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy

Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?, Intensive Care Medicine Experimental

Statin-related myotoxicity Endocrinología y Nutrición (English Edition)

Diagnostics, Free Full-Text

Muscle- and skeletal-related side-effects of statins: tip of the iceberg? - Johann Auer, Helmut Sinzinger, Barry Franklin, Robert Berent, 2016

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

Statin Myopathy.pdf

2018 Guidelines for the management of dyslipidemia

Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations: Molecular Therapy